Meeting
2017 ASCO Annual Meeting
Initiation and shift of antidiabetic therapy and pancreatic cancer.
Authors
Philippe Autier
University of Strathclyde Institute for Global Public Health at iPRI, Ecully, France
Philippe Autier , Matteo Franchi , Maria Bota , Agnès Leclercq , Joeri Guillaume , Nancy Van Damme , Giovanni Corrao , Christian Partensky , Mathieu Boniol , Peter Boyle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4126)
DOI
10.1200/JCO.2017.35.15_suppl.4126
Abstract #
4126
Poster Bd #
118
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Survival and comorbid diabetes mellitus in metastatic hormone-sensitive prostate cancer.
First Author: Priya Baxi
Poster
2017 Gastrointestinal Cancers Symposium
Evaluating associations of diabetes, insulin use, and BMI with efficacy in patients with resected pancreatic cancer: An ancillary analysis of NRG Oncology/RTOG 9704.
First Author: Theodore S. Hong
Poster
2017 Gastrointestinal Cancers Symposium
The effects of pioglitazone treatment on pancreatic cancer-related insulin resistance.
First Author: Jennifer Stern
Poster
2016 Gastrointestinal Cancers Symposium
Impact of concurrent medications use on outcome of pancreatic cancer: SEER Medicare analysis.
First Author: Muhammad Shaalan Beg